- $952.52m
- $6.18bn
- $132.60m
- 41
- 51
- 76
- 56
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 164 | 405 | 66.8 | -2.37 | 133 |
Cost of Revenue | |||||
Gross Profit | 50.3 | 372 | 61.1 | -46 | -82.8 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 317 | 227 | -35.5 | -146 | 139 |
Operating Profit | -153 | 178 | 102 | 143 | -6.13 |
Net Income Before Taxes | -153 | 178 | 102 | 143 | -6.13 |
Net Income After Taxes | -153 | 178 | 102 | 143 | -6.13 |
Net Income Before Extraordinary Items | |||||
Net Income | -153 | 178 | 102 | 143 | -6.13 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -166 | 160 | 90.9 | 135 | -13.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -7.01 | 6.93 | 2.78 | 3.17 | -0.252 |
Dividends per Share |